NASDAQ:CERN - Cerner Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$56.29 +0.04 (+0.07 %)
(As of 11/20/2018 04:00 PM ET)
Previous Close$56.25
Today's Range$55.72 - $56.57
52-Week Range$50.91 - $73.43
Volume1.65 million shs
Average Volume2.20 million shs
Market Capitalization$19.07 billion
P/E Ratio25.59
Dividend YieldN/A
Beta0.96
Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a cloud-based platform that enables organizations to aggregate, transform, and reconcile data across the continuum of care, as well as EHR agnostic platform, CareAware, that facilitates connectivity of health care devices to EHRs. In addition, the company offers a portfolio of clinical and financial health care information technology solutions, as well as departmental, connectivity, population health, and care coordination solutions; and various complementary services, including support, hosting, managed, implementation, and strategic consulting services. Further, it provides various services, such as implementation and training, remote hosting, operational management, revenue cycle, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third party administrator services for employer-based health plans; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri.

Receive CERN News and Ratings via Email

Sign-up to receive the latest news and ratings for CERN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:CERN
Previous Symbol
CUSIP15678210
Phone816-221-1024

Debt

Debt-to-Equity Ratio0.09
Current Ratio2.63
Quick Ratio2.60

Price-To-Earnings

Trailing P/E Ratio25.59
Forward P/E Ratio25.36
P/E Growth1.89

Sales & Book Value

Annual Sales$5.14 billion
Price / Sales3.61
Cash Flow$3.8741 per share
Price / Cash14.53
Book Value$14.40 per share
Price / Book3.91

Profitability

EPS (Most Recent Fiscal Year)$2.20
Net Income$866.97 million
Net Margins15.72%
Return on Equity14.73%
Return on Assets11.00%

Miscellaneous

Employees26,000
Outstanding Shares329,490,000
Market Cap$19.07 billion
OptionableOptionable

Cerner (NASDAQ:CERN) Frequently Asked Questions

What is Cerner's stock symbol?

Cerner trades on the NASDAQ under the ticker symbol "CERN."

How will Cerner's stock buyback program work?

Cerner declared that its board has authorized a stock repurchase program on Sunday, June 4th 2017, which permits the company to buyback $500,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 2.3% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board of directors believes its shares are undervalued.

How were Cerner's earnings last quarter?

Cerner Co. (NASDAQ:CERN) announced its earnings results on Thursday, August, 2nd. The company reported $0.62 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.60 by $0.02. The business earned $1.37 billion during the quarter, compared to analyst estimates of $1.33 billion. Cerner had a net margin of 15.72% and a return on equity of 14.73%. Cerner's quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.61 earnings per share. View Cerner's Earnings History.

When is Cerner's next earnings date?

Cerner is scheduled to release their next quarterly earnings announcement on Tuesday, February 5th 2019. View Earnings Estimates for Cerner.

What guidance has Cerner issued on next quarter's earnings?

Cerner updated its FY 2018 earnings guidance on Thursday, October, 25th. The company provided EPS guidance of $2.46-2.46 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.50. The company issued revenue guidance of $5.396-5.396 billion, compared to the consensus revenue estimate of $5.41 billion.Cerner also updated its Q4 2018 guidance to $0.62-0.64 EPS.

What price target have analysts set for CERN?

17 brokerages have issued twelve-month price targets for Cerner's stock. Their forecasts range from $54.00 to $77.00. On average, they anticipate Cerner's share price to reach $69.91 in the next year. This suggests a possible upside of 24.2% from the stock's current price. View Analyst Price Targets for Cerner.

What is the consensus analysts' recommendation for Cerner?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cerner in the last year. There are currently 6 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cerner.

What are Wall Street analysts saying about Cerner stock?

Here are some recent quotes from research analysts about Cerner stock:
  • 1. According to Zacks Investment Research, "Cerner exited the third quarter on a tepid note. While earnings met the consensus mark, revenues lagged the same. Licensed Software and Subscriptions revenues saw a year-over-year decline in the quarter. In fact, management expects low software bookings to affect total bookings in the fourth quarter. Contraction in gross and operating margins adds to the woes. High long-term debt and competition in the global MedTech space raise concern. The stock has underperformed the industry in a year’s time. Meanwhile, Cerner continues to see contributions from Population Health, Revenue Cycle and ITWorks platforms. Solid year-over-year bookings growth is a positive. Gains in Professional and Managed Services units buoy optimism. Management is optimistic about the alliance with Lumeris, earlier this year. Continued activity with the Department of Veterans Affairs is encouraging. A strong fourth-quarter and full-year outlook is heartening as well." (11/12/2018)
  • 2. Cantor Fitzgerald analysts commented, "Our rating remains Overweight and our PT remains $80. Although some amount of investor skepticism regarding the company’s growth outlook continues to temper valuation levels, we do not share those concerns. Our long-term DCF model assumptions are mostly conservative, with high single-digit revenue growth and modest margin expansion. Capital spending should moderate in 2019. We think the shares offer a compelling risk/reward trade off (including the potential impact from the VA contract). Valuation Summary Cerner shares trade at a 25% discount to our DCF-based price target of $80 (including the VA contract)." (9/12/2018)

Has Cerner been receiving favorable news coverage?

Media coverage about CERN stock has trended somewhat positive this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cerner earned a media sentiment score of 1.9 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 7.0 out of 10, meaning that recent news coverage is likely to have an impact on the company's share price in the next few days.

Are investors shorting Cerner?

Cerner saw a decrease in short interest in October. As of October 15th, there was short interest totalling 7,073,636 shares, a decrease of 16.3% from the September 28th total of 8,454,561 shares. Based on an average trading volume of 1,666,873 shares, the short-interest ratio is currently 4.2 days. Currently, 2.4% of the company's shares are short sold. View Cerner's Current Options Chain.

Who are some of Cerner's key competitors?

Who are Cerner's key executives?

Cerner's management team includes the folowing people:
  • Mr. Clifford W. Illig, Co-Founder & Vice Chairman (Age 67)
  • Mr. Marc G. Naughton, Exec. VP & CFO (Age 63)
  • Mr. Michael R. Nill, Exec. VP & COO (Age 53)
  • Mr. Jeffrey A. Townsend, Exec. VP & Chief of Innovation (Age 54)
  • Mr. David Brent Shafer, Chairman & CEO (Age 61)

Who are Cerner's major shareholders?

Cerner's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.36%), Bank of New York Mellon Corp (4.57%), Loomis Sayles & Co. L P (3.98%), Fiduciary Management Inc. WI (1.87%), Veritas Asset Management LLP (1.36%) and Morgan Stanley (0.97%). Company insiders that own Cerner stock include Clifford W Illig, David Brent Shafer, Denis A Cortese, Gerald E Bisbee, Jr, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, Neal L Patterson, Randy D Sims, William D Zollars and Zane M Burke. View Institutional Ownership Trends for Cerner.

Which major investors are selling Cerner stock?

CERN stock was sold by a variety of institutional investors in the last quarter, including TIAA CREF Investment Management LLC, Bristol John W & Co. Inc. NY, FMR LLC, AXA, Mitsubishi UFJ Trust & Banking Corp, Fiduciary Management Inc. WI, Capital Fund Management S.A. and Teachers Advisors LLC. Company insiders that have sold Cerner company stock in the last year include Clifford W Illig, David Brent Shafer, Denis A Cortese, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael R Battaglioli, William D Zollars and Zane M Burke. View Insider Buying and Selling for Cerner.

Which major investors are buying Cerner stock?

CERN stock was acquired by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, MERIAN GLOBAL INVESTORS UK Ltd, Panagora Asset Management Inc., American Century Companies Inc., Morgan Stanley, Obermeyer Wood Investment Counsel Lllp, Commonwealth Bank of Australia and Los Angeles Capital Management & Equity Research Inc.. View Insider Buying and Selling for Cerner.

How do I buy shares of Cerner?

Shares of CERN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cerner's stock price today?

One share of CERN stock can currently be purchased for approximately $56.29.

How big of a company is Cerner?

Cerner has a market capitalization of $19.07 billion and generates $5.14 billion in revenue each year. The company earns $866.97 million in net income (profit) each year or $2.20 on an earnings per share basis. Cerner employs 26,000 workers across the globe.

What is Cerner's official website?

The official website for Cerner is http://www.cerner.com.

How can I contact Cerner?

Cerner's mailing address is 2800 ROCKCREEK PKWY W0162, NORTH KANSAS CITY MO, 64117. The company can be reached via phone at 816-221-1024 or via email at [email protected]


MarketBeat Community Rating for Cerner (NASDAQ CERN)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  844 (Vote Outperform)
Underperform Votes:  518 (Vote Underperform)
Total Votes:  1,362
MarketBeat's community ratings are surveys of what our community members think about Cerner and other stocks. Vote "Outperform" if you believe CERN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2018 by MarketBeat.com Staff

Featured Article: Relative Strength Index

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel